MedTrace Logo

Electric Field Navigated 1hz Rtms for Post-stroke Motor Recovery Trial

NCT03010462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-04-26

Study results available
· View outcomes & findings →

Summary

A prospective, multi-center, randomized, sham-controlled, blinded study combining active Nexstim NBS-guided 1Hz rTMS or sham-rTMS targeting the healthy hemisphere with standardized task oriented rehabilitation will be conducted in patients with post-stroke motor impairment of the upper limb. The therapy will be provided for 6 weeks and primary outcome assessed 6 months later.

Conditions

Interventions

DEVICE

Nexstim NBS guided active rTMS

Nexstim NBS guided active rTMS + standardized task-oriented therapy

DEVICE

Nexstim NBS guided sham rTMS

Nexstim NBS guided sham rTMS + standardized task-oriented therapy

Sponsors & Collaborators

  • Nexstim Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2018-08-15
Completion
2018-08-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03010462 on ClinicalTrials.gov